GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Onward Medical NV (XBRU:ONWD) » Definitions » EV-to-EBIT
中文

Onward Medical NV (XBRU:ONWD) EV-to-EBIT

: -4.09 (As of Today)
View and export this data going back to 2021. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Onward Medical NV's Enterprise Value is €145.90 Mil. Onward Medical NV's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €-35.70 Mil. Therefore, Onward Medical NV's EV-to-EBIT for today is -4.09.

The historical rank and industry rank for Onward Medical NV's EV-to-EBIT or its related term are showing as below:

XBRU:ONWD' s EV-to-EBIT Range Over the Past 10 Years
Min: -13.65   Med: 0   Max: 0
Current: -4.09

XBRU:ONWD's EV-to-EBIT is ranked worse than
100% of 444 companies
in the Biotechnology industry
Industry Median: 8.325 vs XBRU:ONWD: -4.09

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Onward Medical NV's Enterprise Value for the quarter that ended in Jun. 2023 was €135.06 Mil. Onward Medical NV's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €-35.70 Mil. Onward Medical NV's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -26.43%.


Onward Medical NV EV-to-EBIT Historical Data

The historical data trend for Onward Medical NV's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Onward Medical NV Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-EBIT
Premium Member Only - - - -8.10 -4.38

Onward Medical NV Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -8.10 - -4.38 -

Competitive Comparison

For the Biotechnology subindustry, Onward Medical NV's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Onward Medical NV EV-to-EBIT Distribution

For the Biotechnology industry and Healthcare sector, Onward Medical NV's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Onward Medical NV's EV-to-EBIT falls into.



Onward Medical NV EV-to-EBIT Calculation

Onward Medical NV's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=145.901/-35.698
=-4.09

Onward Medical NV's current Enterprise Value is €145.90 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Onward Medical NV's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €-35.70 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Onward Medical NV  (XBRU:ONWD) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Onward Medical NV's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2023 ) =EBIT / Enterprise Value (Q: Jun. 2023 )
=-35.698/135.05976
=-26.43 %

Onward Medical NV's Enterprise Value for the quarter that ended in Jun. 2023 was €135.06 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Onward Medical NV's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €-35.70 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Onward Medical NV EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Onward Medical NV's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Onward Medical NV (XBRU:ONWD) Business Description

Traded in Other Exchanges
Address
High Tech Campus 32, Noord-Braban, Eindhoven, NH, NLD, NL-5656 AE
Onward Medical NV is a medical technology company developing and commercializing therapies to enable functional recovery for people with spinal cord injury. It has developed two programmable neurostimulation platforms: an implantable system, ARCIM, and a non-invasive, transcutaneous system, ARCEX. The company has selected the United states and four European markets: Germany, France, the UK and the Netherlands to create a customer base.

Onward Medical NV (XBRU:ONWD) Headlines

No Headlines